{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T07:05:09Z","timestamp":1794726309851,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Maternal heart rate artefact is a signal processing error whereby the fetal heart rate is masked by the maternal pulse, potentially leading to danger by failure to recognize an abnormal fetal heart rate or a pre-existing fetal death. Maternal heart rate artefact may be exacerbated by autocorrelation algorithms in modern fetal monitors due to smooth transitions between maternal and fetal heart rates rather than breaks in the tracing. In response, manufacturers of cardiotocography monitors recommend verifying fetal life prior to monitoring and have developed safeguards including signal ambiguity detection technologies to simultaneously and continuously monitor the maternal and fetal heart rates. However, these safeguards are not emphasized in current cardiotocography clinical practice guidelines, potentially leading to a patient safety gap.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The United States Food and Drug Administration Manufacturer and User Facility Device Experience database was reviewed for records with event type \u201cDeath\u201d for the time period March 31, 2009 to March 31, 2019, in combination with search terms selected to capture all cases reported involving cardiotocography devices. Records were reviewed to determine whether maternal heart rate artefact was probable and\/or whether the report contained a recommendation from the device manufacturer regarding maternal heart rate artefact.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Forty-seven cases of perinatal mortality were identified with probable maternal heart rate artefact including 14 with antepartum fetal death prior to initiation of cardiotocography, 14 with intrapartum fetal death or neonatal death after initiation of cardiotocography, and 19 where the temporal relationship between initiation of cardiotocography and death cannot be definitively established from the report. In 29 cases, there was a recommendation from the manufacturer regarding diagnosis and\/or management of maternal heart rate artefact.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This case series indicates a recurring problem with undetected maternal heart rate artefact leading to perinatal mortality and, in cases of pre-existing fetal death, healthcare provider confusion. In response, manufacturers frequently recommend safeguards which are found in their device\u2019s instructions for use but not in major intrapartum cardiotocography guidelines. Cardiotocography guidelines should be updated to include the latest safeguards against the risks of maternal heart rate artefact. An additional file summarizing key points for clinicians is included.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12884-019-2660-5","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T19:03:26Z","timestamp":1576523006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Unrecognized maternal heart rate artefact in cases of perinatal mortality reported to the United States Food and Drug Administration from 2009 to 2019: a critical patient safety issue"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-7825","authenticated-orcid":false,"given":"Daniel J.","family":"Kiely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence W.","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Dornan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"2660_CR1","unstructured":"Miller DA. Intrapartum fetal evaluation. In: Gabbe SG, Niebyl JR, Simpson JL, Landon MB, Galan HL, Jauniaux ERM, Driscoll DA, Berghella V, Grobman WA, editors. Obstetrics: normal and problem pregnancies. 7th ed: Philadelphia: Elsevier; 2017. p. 330."},{"issue":"6","key":"2660_CR2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ajog.2008.02.030","volume":"198","author":"DR Neilson Jr","year":"2008","unstructured":"Neilson DR Jr, Freeman RK, Mangan S. Signal ambiguity resulting in unexpected outcome with external fetal heart rate monitoring. Am J Obstet Gynecol. 2008;198(6):717\u201324.","journal-title":"Am J Obstet Gynecol"},{"key":"2660_CR3","unstructured":"Freeman RK, Garite TJ, Nageotte MP, Miller LA. Fetal heart rate monitoring. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2012."},{"issue":"11","key":"2660_CR4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S1701-2163(15)30408-4","volume":"36","author":"S Paquette","year":"2014","unstructured":"Paquette S, Moretti F, O'Reilly K, Ferraro ZM, Oppenheimer L. The incidence of maternal artefact during intrapartum fetal heart rate monitoring. J Obstet Gynaecol Can. 2014;36(11):962\u20138.","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"2660_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0002-9378(85)80261-1","volume":"153","author":"T Fukushima","year":"1985","unstructured":"Fukushima T, Flores CA, Hon EH, Davidson EC Jr. Limitations of autocorrelation in fetal heart rate monitoring. Am J Obstet Gynecol. 1985;153(6):685\u201392.","journal-title":"Am J Obstet Gynecol"},{"key":"2660_CR6","unstructured":"The National Archives. Philips Healthcare \u2013 Addendum. Additional information regarding ultrasound fetal monitoring (Nov 2009). Internet-accessible document: Philips Healthcare \u2013 Additional Information \u2013 December 2009 (pdf). The National Archives. Archived on 10 Jul 2010. Monitors, foetal: monitor \u2013 Philips Healthcare \u2013 Avalon Fetal Monitors \u2013 updated. 2010. http:\/\/webarchive.nationalarchives.gov.uk\/20100710070437\/http:\/\/www.mhra.gov.uk\/Safetyinformation\/Safetywarningsalertsandrecalls\/FieldSafetyNoticesformedicaldevices\/CON060063."},{"key":"2660_CR7","unstructured":"Philips Healthcare. Instructions for use. Avalon fetal monitor. FM20\/30, FM 40\/50, Avalon CL. Release J.3 with Software Revision J.3x.xx. http:\/\/incenter.medical.philips.com\/default.aspx?tabid=729."},{"key":"2660_CR8","unstructured":"Philips Healthcare. FM20\/30\/40\/50 & CL Avalon Fetal Monitor Rel. J.3 Training Guide 4535 644 94131 (ENG). http:\/\/incenter.medical.philips.com\/default.aspx?tabid=729."},{"key":"2660_CR9","unstructured":"General Electric Healthcare. Common Documentation Library, Clinical Systems. User manuals for: Corometrics 170 series, Corometrics 250 series, Corometrics 250CX Series. http:\/\/apps.gehealthcare.com\/servlet\/ClientServlet?REQ=Enter%2bDocumentation%2bLibrary."},{"key":"2660_CR10","unstructured":"The National Archives. Philips Healthcare. Important device safety alert (20 September 2009). Internet accessible document: Philips Healthcare \u2013 FSN \u2013 October 2009 (pdf). Available at: The National Archives. Archived on 10 Jul 2010. Monitors, foetal: monitor \u2013 Philips Healthcare \u2013 Avalon Fetal Monitors \u2013 updated. 2010. http:\/\/webarchive.nationalarchives.gov.uk\/20100710070437\/http:\/\/www.mhra.gov.uk\/Safetyinformation\/Safetywarningsalertsandrecalls\/FieldSafetyNoticesformedicaldevices\/CON060063."},{"key":"2660_CR11","unstructured":"The National Archives. Philips Healthcare. Urgent \u2013 Medical Device Recall. Philips Avalon Fetal Monitors FM20, FM30, FM40, FM50 (30 November 2009). Internet accessible document: Philips Healthcare \u2013 Update FSN \u2013 December 2009 (pdf). Available at: The National Archives. Archived on 10 Jul 2010. Monitors, foetal: monitor \u2013 Philips Healthcare \u2013 Avalon Fetal Monitors \u2013 updated. 2010. http:\/\/webarchive.nationalarchives.gov.uk\/20100710070437\/http:\/\/www.mhra.gov.uk\/Safetyinformation\/Safetywarningsalertsandrecalls\/FieldSafetyNoticesformedicaldevices\/CON060063."},{"key":"2660_CR12","unstructured":"US Food & Drug Administration. Recalls, corrections, and removals (devices). https:\/\/www.fda.gov\/medicaldevices\/deviceregulationandguidance\/postmarketrequirements\/recallscorrectionsandremovals\/default.htm."},{"key":"2660_CR13","unstructured":"US Food & Drug Administration. MAUDE \u2013 Manufacturer and User Facility Device Experience website. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm."},{"key":"2660_CR14","unstructured":"United States Food and Drug Administration. Open FDA. Manufacturer and User Facility Device Experience. https:\/\/open.fda.gov\/data\/maude\/."},{"issue":"3","key":"2660_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ajog.2017.12.204","volume":"218","author":"DJ Kiely","year":"2018","unstructured":"Kiely DJ. A 2009 fetal monitor recall that arguably should have been class I. Am J Obstet Gynecol. 2018;218(3):369.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2660_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ajog.2018.04.036","volume":"219","author":"DJ Kiely","year":"2018","unstructured":"Kiely DJ. Did the maternal pulse mask the fetal heart rate of acidemic infants with no explanatory features? Am J Obstet Gynecol. 2018;219(3):314.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2660_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1701-2163(15)30304-2","volume":"37","author":"DJ Kiely","year":"2015","unstructured":"Kiely DJ. The incidence of maternal Artefact during Intrapartum fetal heart rate monitoring. J Obstet Gynaecol Can. 2015;37(3):205\u20136.","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"2660_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jogc.2017.01.019","volume":"39","author":"DJ Kiely","year":"2017","unstructured":"Kiely DJ. Management of Spontaneous Labour at term in healthy women. J Obstet Gynaecol Can. 2017;39(4):220\u20131.","journal-title":"J Obstet Gynaecol Can"},{"key":"2660_CR19","doi-asserted-by":"publisher","unstructured":"Kiely DJ, Oppenheimer LW, Dornan JC. 117 cases from the FDA MAUDE database involving event type death and cardiotocography devices; 2019. https:\/\/doi.org\/10.6084\/m9.figshare.9730169. https:\/\/figshare.com\/articles\/Full_list_of_117_cases_of_CTG-associated_fetal_or_neonatal_deaths\/9730169.","DOI":"10.6084\/m9.figshare.9730169"},{"key":"2660_CR20","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.9730172","volume-title":"47 cases from US FDA MAUDE database, event type death, cardiotocography device and probable MHRA","author":"DJ Kiely","year":"2019","unstructured":"Kiely DJ, Oppenheimer LW, Dornan JC. 47 cases from US FDA MAUDE database, event type death, cardiotocography device and probable MHRA; 2019. https:\/\/doi.org\/10.6084\/m9.figshare.9730172. https:\/\/figshare.com\/articles\/47_cases_with_probable_MHRA\/9730172."},{"key":"2660_CR21","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.9730175.v1","volume-title":"29 cases from US FDA MAUDE database involving event type death, cardiotocography devices, and a recommendation from the manufacturer regarding MHRA","author":"DJ Kiely","year":"2019","unstructured":"Kiely DJ, Oppenheimer LW, Dornan JC. 29 cases from US FDA MAUDE database involving event type death, cardiotocography devices, and a recommendation from the manufacturer regarding MHRA; 2019. https:\/\/doi.org\/10.6084\/m9.figshare.9730175.v1. https:\/\/figshare.com\/articles\/29_cases_with_recommendations_relating_to_MHRA\/9730175."},{"key":"2660_CR22","doi-asserted-by":"publisher","unstructured":"Kiely DJ, Oppenheimer LW, Dornan JC. 14 cases of neonatal death or intrapartum stillbirth involving probable MHRA from US FDA MAUDE database; 2019. https:\/\/doi.org\/10.6084\/m9.figshare.9730178.v1. https:\/\/figshare.com\/articles\/14_cases_of_neonatal_death_or_intrapartum_stillbirth_with_probable_MHRA\/9730178.","DOI":"10.6084\/m9.figshare.9730178.v1"},{"key":"2660_CR23","unstructured":"United States Food and Drug Administration. FDA MAUDE database report, Report number, 9610816-\u00ad2017-\u00ad00372. 2017. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfMAUDE\/detail.cfm?mdrfoi__id=7063061&pc=HGM."},{"key":"2660_CR24","unstructured":"United States Food and Drug Administration. FDA MAUDE database report, Report number, 9610816-\u00ad2017-\u00ad00333. 2017. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfMAUDE\/detail.cfm?mdrfoi__id=6951421&pc=HGM."},{"key":"2660_CR25","unstructured":"United States Food and Drug Administration. FDA MAUDE database report, Report number 9610816\u00ad-2017-\u00ad00181. 2017. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfMAUDE\/detail.cfm?mdrfoi__id=6633726&pc=HGM."},{"key":"2660_CR26","unstructured":"United States Food and Drug Administration. FDA MAUDE database report, Report number, 9610816-\u00ad2015-\u00ad00081. 2015 https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfMAUDE\/detail.cfm?mdrfoi__id=4710453&pc=HGM."},{"key":"2660_CR27","unstructured":"United States Food and Drug Administration. FDA MAUDE database report, Report number 9610816-\u00ad2011-\u00ad00116. 2011. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfMAUDE\/detail.cfm?mdrfoi__id=2012314&pc=HGM."},{"key":"2660_CR28","unstructured":"United States Food and Drug Administration. FDA MAUDE database report, Report number, 9610816-\u00ad2018-\u00ad00035 2018. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfMAUDE\/detail.cfm?mdrfoi__id=7233465&pc=HGM."},{"key":"2660_CR29","unstructured":"United States Food and Drug Administration. FDA MAUDE database report, Report number, 9617277-\u00ad2013-\u00ad00001. 2013. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfMAUDE\/detail.cfm?mdrfoi__id=3369763&pc=HGM."},{"issue":"3","key":"2660_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0020-7292(90)90013-B","volume":"33","author":"A Herman","year":"1990","unstructured":"Herman A, Ron-El R, Arieli S, Schreyer P, Caspi E. Maternal ECG recorded by internal monitoring closely mimicking fetal heart rate in a recent fetal death. Int J Gynecol Obstet. 1990;33(3):269\u201371.","journal-title":"Int J Gynecol Obstet"},{"issue":"6","key":"2660_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/1520-6661(200011\/12)9:6<360::AID-MFM1008>3.0.CO;2-Y","volume":"9","author":"Patrick S. Ramsey","year":"2000","unstructured":"Ramsey PS, Johnston BW, Welter VE, Ogburn PL, Jr. Artifactual fetal electrocardiographic detection using internal monitoring following intrapartum fetal demise during VBAC trial. J Matern Fetal Med. 2000;9(6):360\u20131.","journal-title":"The Journal of Maternal-Fetal Medicine"},{"issue":"4","key":"2660_CR32","first-page":"126","volume":"11","author":"R Achiron","year":"1984","unstructured":"Achiron R, Zakut H. Misinterpretation of fetal heart rate monitoring in case of intrauterine death. Clin Exp Obstet Gynecol. 1984;11(4):126\u20139.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"3 Suppl","key":"2660_CR33","doi-asserted-by":"publisher","first-page":"28s","DOI":"10.1097\/00006250-198003001-00009","volume":"55","author":"JM Barrett","year":"1980","unstructured":"Barrett JM, Boehm FH. Documentation of recent fetal demise with simultaneous maternal and fetal heart rate monitoring. Obstet Gynecol. 1980;55(3 Suppl):28s\u201330s.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2660_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijgo.2015.06.020","volume":"131","author":"D Ayres-de-Campos","year":"2015","unstructured":"Ayres-de-Campos D, Spong CY, Chandraharan E. FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography. Int J Gynecol Obstet. 2015;131(1):13\u201324.","journal-title":"Int J Gynecol Obstet"},{"key":"2660_CR35","unstructured":"National Institute for Health and Care Excellence. Intrapartum care for healthy women and babies. 2014. https:\/\/www.nice.org.uk\/guidance\/cg190."},{"issue":"5","key":"2660_CR36","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1097\/AOG.0b013e3182004fa9","volume":"116","author":"The American College of Obstetricians and Gynecologists. Practice bulletin no","year":"2010","unstructured":"The American College of Obstetricians and Gynecologists. Practice bulletin no. 116: management of intrapartum fetal heart rate tracings. Obstet Gynecol. 2010;116(5):1232\u201340.","journal-title":"Obstet Gynecol"},{"key":"2660_CR37","unstructured":"The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Intrapartum Fetal Surveillance. Clinical Guideline - Third Edition 2014. https:\/\/www.ranzcog.edu.au\/RANZCOG_SITE\/media\/RANZCOG-MEDIA\/Women%27s%20Health\/Statement%20and%20guidelines\/Clinical-Obstetrics\/Intrapartum-Fetal-Surveillance-Guideline-Third-edition-Aug-2014.pdf?ext=.pdf."},{"issue":"4","key":"2660_CR38","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.jogc.2018.02.007","volume":"40","author":"R Liston","year":"2018","unstructured":"Liston R, Sawchuck D, Young D. No. 197a-fetal health surveillance: antepartum consensus guideline. J Obstet Gynaecol Can. 2018;40(4):e251\u2013e71.","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"2660_CR39","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1016\/j.jogc.2018.02.011","volume":"40","author":"R Liston","year":"2018","unstructured":"Liston R, Sawchuck D, Young D. No. 197b-fetal health surveillance: Intrapartum consensus guideline. J Obstet Gynaecol Can. 2018;40(4):e298\u2013322.","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"2660_CR40","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1016\/j.jogc.2018.02.013","volume":"40","author":"R Liston","year":"2018","unstructured":"Liston R, Sawchuck D, Young D. No. 197c-maintaining standards in antenatal and Intrapartum fetal surveillance: quality improvement and risk management. J Obstet Gynaecol Can. 2018;40(4):e353\u2013e8.","journal-title":"J Obstet Gynaecol Can"},{"key":"2660_CR41","unstructured":"Health Service Executive Ireland. Intrapartum fetal heart rate monitoring. Clinical Practice Guideline. 2014; https:\/\/www.hse.ie\/eng\/about\/who\/acute-hospitals-division\/woman-infants\/clinical-guidelines\/."},{"issue":"4","key":"2660_CR42","first-page":"542","volume":"99","author":"DJ Sherman","year":"2002","unstructured":"Sherman DJ, Frenkel E, Kurzweil Y, Padua A, Arieli S, Bahar M. Characteristics of maternal heart rate patterns during labor and delivery. Obstet Gynecol. 2002;99(4):542\u20137.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2660_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0884217503261161","volume":"33","author":"ML Murray","year":"2004","unstructured":"Murray ML. Maternal or fetal heart rate? Avoiding intrapartum misidentification. J Obstet, Gynecol, Neonatal Nurse : JOGNN. 2004;33(1):93\u2013104.","journal-title":"J Obstet, Gynecol, Neonatal Nurse : JOGNN"},{"issue":"49","key":"2660_CR44","first-page":"1963","volume":"50","author":"HJ Odendaal","year":"1976","unstructured":"Odendaal HJ. False interpretation of fetal heart role monitoring in cases of intra-uterine death. S Afr Med J. 1976;50(49):1963\u20135.","journal-title":"S Afr Med J"},{"issue":"1","key":"2660_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12884-015-0739-1","volume":"15","author":"P Pinto","year":"2015","unstructured":"Pinto P, Costa-Santos C, Gon\u00e7alves H, Ayres-De-Campos D, Bernardes J. Improvements in fetal heart rate analysis by the removal of maternal-fetal heart rate ambiguities. BMC Pregnancy Childbirth. 2015;15(1):301.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9","key":"2660_CR46","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3109\/14767058.2015.1051019","volume":"29","author":"P Pinto","year":"2016","unstructured":"Pinto P, Costa-Santos C, Ayres-de-Campos D, Bernardes J. Computer analysis of maternal-fetal heart rate recordings during labor in relation with maternal-fetal attachment and prediction of newborn acidemia. J Matern Fetal Neonatal Med. 2016;29(9):1440\u20134.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"2660_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11517-015-1359-7","volume":"54","author":"H Goncalves","year":"2016","unstructured":"Goncalves H, Pinto P, Silva M, Ayres-de-Campos D, Bernardes J. Toward the improvement in fetal monitoring during labor with the inclusion of maternal heart rate analysis. Med Biol Eng Comput. 2016;54(4):691\u20139.","journal-title":"Med Biol Eng Comput"},{"issue":"7237","key":"2660_CR48","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/bmj.320.7237.726","volume":"320","author":"AW Wu","year":"2000","unstructured":"Wu AW. Medical error: the second victim. The doctor who makes the mistake needs help too. BMJ. 2000;320(7237):726\u20137.","journal-title":"BMJ"},{"key":"2660_CR49","unstructured":"World Health Organization. Sexual and reproductive health. Helping mothers get the best care during childbirth. https:\/\/www.who.int\/reproductivehealth\/news\/childbirth-checklist\/en\/."},{"issue":"Suppl 1","key":"2660_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/pr.2013.206","volume":"74","author":"AC Lee","year":"2013","unstructured":"Lee AC, Kozuki N, Blencowe H, Vos T, Bahalim A, Darmstadt GL, et al. Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatr Res. 2013;74(Suppl 1):50\u201372.","journal-title":"Pediatr Res"},{"issue":"4","key":"2660_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00000542-199204000-00001","volume":"76","author":"D Gaba","year":"1992","unstructured":"Gaba D. Improving Anesthesiologists' performance by simulating reality. Anesthesiology. 1992;76(4):491\u20134.","journal-title":"Anesthesiology."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-019-2660-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:23:42Z","timestamp":1607991822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-019-2660-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1186\/s12884-019-2660-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"19 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study design was submitted to the institutional review board of Centre int\u00e9gr\u00e9 de sant\u00e9 et de services sociaux de Chaudi\u00e8re-Appalaches and granted an exemption on the basis that the data involved is openly available to the public. Consent to participate is not applicable to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent has been obtained from the patient to publish Fig. .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no financial or non-financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}